01 42Care4 Aps
02 15Abacus Medicine A/S
03 1Amryt Pharmaceuticals Dac
04 4BIOINDUSTRIA L.I.M. SpA
05 1BIOINDUSTRY ITALIAN LABORATORY MEDICINALI SPA
06 3CHEMI SPA
07 3CHEMI SpA
08 4Campus Pharma Ab
09 1Cc Pharma Nordic Aps
10 3Central Procurement & Supplies Unit
11 2Cherubino Limited
12 9Cross Pharma Ab
13 1EJ Busuttil Ltd
14 3Ebb Medical Ab
15 1Farmak JSC
16 3Fresenius Kabi Ab
17 3Fresenius Kabi Limited
18 3Gp Pharm
19 4Gp Pharm Sa
20 4HOSPIRA ITALIA Srl
21 4Hospira UK Limited
22 7ITALFARMACO SpA
23 3LIFEPHARMA SPA
24 3LIFEPHARMA SpA
25 4Labatec Pharma Sa
26 1Lyomark Pharma Gmbh
27 15Medartuum Ab
28 3Mepha Pharma Ag
29 3Northern Medical Group Aps
30 5Novartis Ireland Limited
31 6Novartis Pharma Schweiz Ag
32 6Novartis Pharmaceuticals Sa
33 7Novartis Sweden Ab
34 1Orifarm AS
35 12Orifarm Ab
36 7Paranova Pharmaceuticals Ab
37 4Pfizer Ab
38 2Pfizer Sl
39 3Ratiopharm Espana Sa
40 4SUN PHARMACEUTICAL IND. BV
41 4SUN PHARMACEUTICAL IND.EU.B.V.
42 4Sun Pharmaceutical - Netherlands
43 4Sun Pharmaceutical Industries (Europe) Bv
44 4Sun Pharmaceutical Industries Europe Bv
45 6Teva Bv
46 2Teva Sweden Ab
47 3The Fresenius Kabi Norge AS - Halden
48 2Uab Bijon Medica
01 87Octreotide
02 114Octreotide Acetate
01 1Capsule
02 3Injectable And Infusion Solution
03 3Injectable And Perfusion Solution
04 57Injectable Solution
05 11Injection fluid, resolution
06 1Octreotide 0.05Mg 10 Units Parenteral Use
07 1Octreotide 0.1Mg 10 Units Parenteral Use
08 1Octreotide 0.5Mg 10 Units Parenteral Use
09 1Octreotide 0.5Mg 3 Units' Parenteral Use
10 5Octreotide 100Mcg 5 Units Parenteral Use
11 1Octreotide 10Mg 1 Unit Parenteral Use
12 4Octreotide 1Mg 1 Unit Parenteral Use
13 1Octreotide 20Mg 1 Unit Parenteral Use
14 1Octreotide 30Mg 1 Unit Parenteral Use
15 4Octreotide 500Mcg 5 Units Parenteral Use
16 5Octreotide 50Mcg 5 Units Parenteral Use
17 3Powder And Solvent For Extended-Release Injectable Suspension
18 7Powder And Solvent For Injectable Suspension
19 6Powder And Solvent For Prolonged-Release Injectable Suspension
20 31Powder For Injection
21 1Powder and liquid to the injection fluid, suspension
22 1Solution
23 30Solution For Injection
24 4Solution For Injection And Infusion
25 5Solution For Injection In Pre-Filled
26 1Solution For Injection In Pre-Filled Syringe
27 1Solution For Injection Or Concentrate For Solution For Infusion
28 10Solution For Injection/Infusion
29 1Solution for Injection
01 36Italy
02 14Malta
03 12Norway
04 22Spain
05 103Sweden
06 13Switzerland
07 1Ukraine
01 4Longastatina
02 3Longastatina Lar
03 1Mycapssa
04 1OCTREOTIDE BIOINDUSTRY LIM
05 4OCTREOTIDE SUN
06 1Octra
07 2Octreo-Ratiopharm
08 4Octreotida Gp-Pharm
09 2Octreotida Hospira
10 3Octreotida Ratiopharm
11 4Octreotida Sun
12 3Octreotida Teva
13 15Octreotide
14 3Octreotide 2Care4
15 3Octreotide Abacus Medicine
16 2Octreotide Bendalis
17 2Octreotide Bijon
18 4Octreotide Campus
19 3Octreotide Csc
20 6Octreotide Fresenius Kabi
21 8Octreotide Hospira
22 4Octreotide Labatec
23 2Octreotide Orifarm
24 4Octreotide Sun
25 6Octreotide Teva
26 3Octreotide-Mepha LA
27 1Octroflex
28 4Oktreotid SUN
29 2Olatuton
30 3SIROCTID
31 44Sandostatin
32 1Sandostatin ALLOWS
33 3Sandostatin LAR Fertigspritzen
34 34Sandostatin Lar
35 3Sandostatina
36 3Siroctid
37 3TREOJECT
38 3Treoject
Regulatory Info :
Registration Country : Italy
Brand Name : Siroctid
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 Syringes 1 ml 0. 1 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Siroctid
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 Syringes 1 ml 0.05 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Octreotide
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.1 mg/1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Octreotide
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.05 mg/1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Longastatina
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.1 mg 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Longastatina
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.05 mg 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Octreotide
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.1 mg/1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Octreotide
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 VIALS EV SC 0.05 mg 1 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Treoject
Dosage Form : Octreotide 100Mcg 5 Units Parenteral Use
Dosage Strength : 5 Syringes EV SC 1 ml 0. 1 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Treoject
Dosage Form : Octreotide 50Mcg 5 Units Parenteral Use
Dosage Strength : 5 Syringes EV SC 1 ml 0.05 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Contact Us!
